With Treatment
Pennsylvania Psychiatric Institute Advancement In Recovery Program is treatment facility located at 2501 North 3rd Street in the 17110 zip code in Harrisburg, PA that offers medication-assisted substance use treatment. It accepts pregnant/postpartum women, adult women and people with trauma into its treatment program. Pennsylvania Psychiatric Institute Advancement In Recovery Program provides suboxone prescription, naltrexone administration and methadone maintenance to children and adolescents. Some of the treatment approaches used by Pennsylvania Psychiatric Institute Advancement In Recovery Program consist of 12-step facilitation, motivational interviewing and matrix Model.
Address: 2501 North 3rd Street, Harrisburg, PA 17110
Here are the full facility listing details on Pennsylvania Psychiatric Institute Advancement in Recovery Program in Harrisburg, PA:
Types of Care at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Service Settings at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Hospitals at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Opioid Medications used in Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Type of Alcohol Use Disorder Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Type Of Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Pharmacotherapies at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Treatment Approaches at Pennsylvania Psychiatric Institute Advancement In Recovery Program
FacilityOwnership at Pennsylvania Psychiatric Institute Advancement In Recovery Program
License/Certification/Accreditation at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Payment/Insurance/Funding Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Special Programs/ Population Groups Supported at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Assessment/Pre-treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Screening & Testing at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Transitional Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Ancillary Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Other Addictions Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Counseling Services and Education at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Tobacco/Screening Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Facility Smoking Policy at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Age Groups Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Gender Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program
Phone #: 717-782-6844
Call (866) 434-2077 for 24/7 help with treatment.
Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Pennsylvania Psychiatric Institute Advancement in Recovery Program. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.
Here are some key points to consider regarding the safety of methadone treatment:
Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.
Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.
Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).
Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.
Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.
However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.
Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Pennsylvania Psychiatric Institute Advancement in Recovery Program to conduct a thorough assessment before starting someone on methadone.
Other drug and rehab centers within 75 miles of Pennsylvania Psychiatric Institute Advancement in Recovery Program: